FindMyRecallSubscribe
Class I: serious health riskTerminated

Apotex Piperacillin and Tazobactam for Injection Recall

Piperacillin and Tazobactam for Injection, USP, 40

Apotex Corp. · Weston, FL

Risk level
Class I
Reported by FDA
Jul 24, 2013
Recall ID
D-806-2013
Check your lot numberHow we source this data

Summary

Apotex recalled Piperacillin and Tazobactam for Injection starting Mar 18, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-806-2013 on Jul 24, 2013. Reason: Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution. Status: Terminated.

Why it was recalled

Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.

Product description

Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0.

Lot numbers, UPCs & expiration codes

Lot #: 503B015, 503B016, Exp 04/13; 503B019, 503B020, 503B021, 503B022, Exp 07/13; 503B024, Exp 08/13; 503B025, 503B026, 503B027, Exp 09/13; 503C005, 503C006, Exp 12/13; 503C007, 503C008, Exp 01/14; 503C018, Exp 04/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-806-2013
Classification
Class I
Status
Terminated
Recall initiated
Mar 18, 2013
FDA report date
Jul 24, 2013
Quantity
37,303 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-806-2013, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Terminated
Country
United States
Event ID
64657
Address
2400 N Commerce Pkwy Ste 400
Code information
Lot #: 503B015, 503B016, Exp 04/13; 503B019, 503B020, 503B021, 503B022, Exp 07/13; 503B024, Exp 08/13; 503B025, 503B026, 503B027, Exp 09/13; 503C005, 503C006, Exp 12/13; 503C007, 503C008, Exp 01/14; 503C018, Exp 04/14
Postal code
33326-3253
Report date
Jul 24, 2013
Product type
Drugs
Recall number
D-806-2013
Classification
Class I
Recalling firm
Apotex Corp.
Product quantity
37,303 vials
Termination date
Jan 8, 2018
Reason for recall
Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0.
Distribution pattern
Nationwide
Recall initiation date
Mar 18, 2013
Initial firm notification
Letter
Center classification date
Jul 17, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-806-2013, published Jul 24, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls